Playlist
Regional Elections to the Mejlis and Halk Maslahaty Scheduled in Turkmenistan
08 Jan. 06:39On March 29, Turkmenistan will hold a new round of regional elections involving both the national parliament and local representative bodies. The Mejlis of Turkmenistan has formally approved the organization of elections to fill vacant seats and establish representation in newly created administrative districts.
As part of the electoral process in Turkmenistan, members of the halk maslahaty will be elected in recently formed etraps across several velayats. In addition, voters will select new deputies to replace those who left the Mejlis of Turkmenistan and local councils ahead of schedule. The elections will take place in districts of the Ahal, Dashoguz, Lebap and Mary velayats of Turkmenistan.
Supplementary parliamentary elections are also planned in Turkmenistan for constituencies “Amyderýa” and “Darganata” in the Lebap velayat, as well as two constituencies in the Mary velayat, due to early termination of mandates.
The resolution was adopted in full compliance with the Electoral Code of Turkmenistan and was officially signed by the Chairperson of the Mejlis of Turkmenistan on January 7.
Also read
Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.
Also read
Blitz